Eledon Pharmaceuticals Statistics
Total Valuation
ELDN has a market cap or net worth of $297.61 million. The enterprise value is $187.08 million.
| Market Cap | 297.61M |
| Enterprise Value | 187.08M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ELDN has 77.30 million shares outstanding. The number of shares has increased by 50.11% in one year.
| Current Share Class | 77.19M |
| Shares Outstanding | 77.30M |
| Shares Change (YoY) | +50.11% |
| Shares Change (QoQ) | +17.20% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 51.22% |
| Float | 70.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.91 |
| P/TBV Ratio | 4.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.44, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.44 |
| Quick Ratio | 8.30 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -72.68% and return on invested capital (ROIC) is -49.93%.
| Return on Equity (ROE) | -72.68% |
| Return on Assets (ROA) | -35.10% |
| Return on Invested Capital (ROIC) | -49.93% |
| Return on Capital Employed (ROCE) | -64.91% |
| Weighted Average Cost of Capital (WACC) | 9.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.37M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ELDN has paid $35,000 in taxes.
| Income Tax | 35,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.24% in the last 52 weeks. The beta is 0.96, so ELDN's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +13.24% |
| 50-Day Moving Average | 3.77 |
| 200-Day Moving Average | 2.82 |
| Relative Strength Index (RSI) | 50.55 |
| Average Volume (20 Days) | 1,947,028 |
Short Selling Information
The latest short interest is 7.50 million, so 9.70% of the outstanding shares have been sold short.
| Short Interest | 7.50M |
| Short Previous Month | 7.28M |
| Short % of Shares Out | 9.70% |
| Short % of Float | 10.71% |
| Short Ratio (days to cover) | 7.69 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -86.47M |
| Pretax Income | -78.11M |
| Net Income | -78.15M |
| EBITDA | n/a |
| EBIT | -86.47M |
| Earnings Per Share (EPS) | -$0.86 |
Balance Sheet
The company has $111.09 million in cash and $555,000 in debt, with a net cash position of $110.53 million or $1.43 per share.
| Cash & Cash Equivalents | 111.09M |
| Total Debt | 555,000 |
| Net Cash | 110.53M |
| Net Cash Per Share | $1.43 |
| Equity (Book Value) | 100.46M |
| Book Value Per Share | 1.32 |
| Working Capital | 100.12M |
Cash Flow
| Operating Cash Flow | -68.89M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -68.89M |
| FCF Per Share | -$0.89 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -50.11% |
| Shareholder Yield | -50.11% |
| Earnings Yield | -26.26% |
| FCF Yield | -23.15% |
Analyst Forecast
The average price target for ELDN is $9.00, which is 133.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 133.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 5, 2020. It was a reverse split with a ratio of 1:18.
| Last Split Date | Oct 5, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |